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Peter Pan bone cells undermine skeleton
T
he skeleton’s construction work-
ers are cells known as osteo-
blasts. A little-known protein 
called Osteopotentia helps these cells grow 
up and produce strong bones, Sohaskey 
et al. show (1).
Osteoblasts pump out type I collagen, 
the protein that accounts for almost all the 
non-mineral content of bone (2). “The 
main point of being an osteoblast is to 
make collagen,” says lead author Mike 
Sohaskey, a postdoc in the lab of Richard 
Harland. As they are synthesized, type I 
collagen molecules feed into the rough 
endoplasmic reticulum (ER), where they 
are modifi  ed and folded into shape (3). 
The osteoblast then secretes the proteins 
for further processing and assembly into 
fi  brils, the functional units of collagen.
Bone construction surges before birth 
and during childhood. During this peri-
od, osteoblasts amass additional rough 
ER to cope with their increased collagen 
output. How the cells manage these 
changes isn’t known, but the protein 
Osteopotentia could be involved because 
its loss disrupts skeletal growth (4).
Sohaskey et al. studied mice with a 
disabled  osteopotentia gene. Bone 
building falters in osteogenesis imper-
fecta (OI), a rare disease 
characterized by a brit-
tle, fracture-prone skele-
ton. The phenotype of 
mice lacking a working 
copy of the osteopotentia 
gene resembled that of 
OI patients in several 
ways. They were smaller 
than normal, and their 
bones were thin and 
snapped easily.
The problem was a case of arrested 
development: without Osteopotentia, many 
immature osteoblasts didn’t grow up. 
Refl   ecting their immaturity, cultures of 
the cells fashioned up to 80% less type I 
collagen than normal. Some of the osteo-
blasts even morphed into osteocytes, a 
cell type that produces little bone.
Osteoblasts partner with osteoclasts—
cells that demolish bone—to fi  ne-tune the 
strength of the skeleton (5). Overactive 
osteoclasts could explain the animals’ 
fragile bones. But, to their surprise, Sohas-
key et al. discovered that the rodents har-
bored sluggish osteoclasts. So although the 
animals create less bone than normal, they 
also dissolve less.
Where Osteopotentia settled had 
been a mystery, but the team traced the 
protein to the rough ER—the right place 
to alter collagen synthe-
sis. The protein enables 
the cell to expand the 
rough ER and meet the 
need for more collagen. In 
cells lacking Osteopoten-
tia, the organelle’s mem-
branes were small and 
fragmented.
The fi  ndings  suggest 
that Osteopotentia is a triple 
threat, controlling collagen 
production, rough ER size, and osteo-
blast maturation. “This gives us a whole 
new perspective on a pathway responsi-
ble for bone formation,” says Sohaskey. 
He speculates that in the mice lacking 
Osteopotentia, problems start early in 
life, when collagen demand climbs. But 
osteoblasts manufacture little collagen. 
That scarcity holds back the cells because 
they require surroundings that are rich 
in the protein to mature. The end result is 
a fragile skeleton.
How Osteopotentia affects ER struc-
ture is one open question. Sohaskey et 
al. also want to determine whether 
faulty Osteopotentia is the culprit in any 
human diseases. OI patients typically 
carry a mutation in one of the two col-
lagen genes. But both genes are normal 
in some sufferers, suggesting that other 
genetic glitches can trigger the disease. 
In the team’s preliminary study of OI 
patients, none had a defective osteopo-
tentia gene, but the researchers plan to 
check for mutations in a broader range 
of patients.
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Richard Harland (left), Mike Sohaskey, and colleagues discovered that the protein 
Osteopotentia reinforces the skeleton by prodding bone-making osteoblasts to mature. Mice 
lacking the protein have a weak skeleton and suffer frequent breaks. In this CT image of 
the rib cage of one of these mice (far right), the yellow arrows point to “fracture calluses” 
that formed at the junctions of the ribs and vertebrae. The middle image shows a normal 
mouse rib cage.
“This gives us 
a whole new 
perspective 
on a pathway 
responsible 
for bone 
formation.”
Protein that controls maturation of bone-building cells might be disease culprit.
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